Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 1:46 pm Purchase | 2021-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | BIOTECHNOLOGY VALUE FUND L P | 1,611,698 6.900% | 1,611,698 (New Position) | Filing History |
| 2022-02-14 1:43 pm Purchase | 2021-12-31 | 13G | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 4,565,242 9.990% | 859,953 (+23.21%) | Filing History |
| 2022-02-14 1:41 pm Sale | 2021-12-31 | 13G | AC IMMUNE SA SHS ACIU | BIOTECHNOLOGY VALUE FUND L P | 7,062,379 9.700% | -854,279 (-10.79%) | Filing History |
| 2022-02-14 1:38 pm Purchase | 2021-12-31 | 13G | COGENT BIOSCIENCES INC COGT | BIOTECHNOLOGY VALUE FUND L P | 3,114,532 7.500% | 282 (+0.01%) | Filing History |
| 2022-02-14 1:35 pm Purchase | 2021-12-31 | 13G | IKENA ONCOLOGY INC IKNA | BIOTECHNOLOGY VALUE FUND L P | 149,864 5.000% | 16,559 (+12.42%) | Filing History |
| 2022-02-14 1:33 pm Purchase | 2021-12-31 | 13G | VIRACTA THERAPEUTICS INC VIRX | BIOTECHNOLOGY VALUE FUND L P | 3,731,744 9.900% | 1,917,436 (+105.68%) | Filing History |
| 2022-02-14 1:30 pm Purchase | 2021-12-31 | 13G | MOLECULAR TEMPLATES INC MTEM | BIOTECHNOLOGY VALUE FUND L P | 225,307 6.000% | 41,232 (+22.40%) | Filing History |
| 2022-02-14 1:27 pm Purchase | 2021-12-31 | 13G | SPERO THERAPEUTICS INC SPRO | BIOTECHNOLOGY VALUE FUND L P | 3,411,520 9.990% | 643,242 (+23.24%) | Filing History |
| 2022-02-14 1:23 pm Purchase | 2021-12-31 | 13G | CULLINAN THERAPEUTICS INC CGEM | BIOTECHNOLOGY VALUE FUND L P | 5,369,459 12.300% | 975,000 (+22.19%) | Filing History |
| 2022-02-14 1:18 pm Sale | 2021-12-31 | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | BIOTECHNOLOGY VALUE FUND L P | 57,438 1.500% | -106,766 (-65.02%) | Filing History |
| 2022-02-14 1:15 pm Purchase | 2021-12-31 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | BIOTECHNOLOGY VALUE FUND L P | 1,589,495 5.400% | 451,731 (+39.70%) | Filing History |
| 2022-02-14 1:12 pm Purchase | 2021-12-31 | 13G | SYNDAX PHARMACEUTICALS INC SNDX | BIOTECHNOLOGY VALUE FUND L P | 4,931,879 8.900% | 1,221,190 (+32.91%) | Filing History |
| 2022-02-14 1:05 pm Purchase | 2021-12-31 | 13G | REGULUS THERAPEUTICS INC RGLS | BIOTECHNOLOGY VALUE FUND L P | 966,124 9.990% | 261,078 (+37.03%) | Filing History |
| 2022-02-14 1:02 pm Purchase | 2021-12-31 | 13G | X4 PHARMACEUTICALS INC XFOR | BIOTECHNOLOGY VALUE FUND L P | 100,922 9.990% | 43,601 (+76.06%) | Filing History |
| 2022-02-14 12:59 pm Sale | 2021-12-31 | 13G | FORWARD PHARMA A/S SPONSORED A FWPAY | BIOTECHNOLOGY VALUE FUND L P | 25,239 7.300% | -10,532 (-29.44%) | Filing History |
| 2022-02-14 12:56 pm Purchase | 2021-12-31 | 13G | BIONOMICS LTD ADS BNOX | BIOTECHNOLOGY VALUE FUND L P | 14,174,157 13.000% | 14,174,157 (New Position) | Filing History |
| 2022-02-14 12:53 pm Purchase | 2021-12-31 | 13G | GH RESH PLC SHS GHRS | BIOTECHNOLOGY VALUE FUND L P | 9,275,158 17.800% | 9,275,158 (New Position) | Filing History |
| 2022-02-11 9:11 pm Purchase | 2021-12-31 | 13G | REPARE THERAPEUTICS INC RPTX | BIOTECHNOLOGY VALUE FUND L P | 4,858,761 11.600% | 1,136,363 (+30.53%) | Filing History |
| 2022-02-11 9:03 pm Purchase | 2021-12-31 | 13G | PROTAGONIST THERAPEUTICS INC C PTGX | BIOTECHNOLOGY VALUE FUND L P | 4,891,945 9.990% | 616,980 (+14.43%) | Filing History |
| 2022-02-11 8:57 pm Sale | 2021-12-31 | 13G | REVOLUTION MEDICINES INC RVMD | BIOTECHNOLOGY VALUE FUND L P | 1,810,549 2.500% | -1,946,500 (-51.81%) | Filing History |